We advised TSG Solutions, the European leader in technical services for responsible mobility solutions, on the acquisition of Nordic Gas Solutions, a gas specialist specialising in the design, assembly, installation, and maintenance of high-standard facilities for natural gas and biogas for safe and environmentally sound management. Nordic Gas Solutions is headquartered in Stockholm, Sweden, and […]
We advised biotech laser startup Oxipit on attracting EUR 3.5 million in investment from the Taiwanese venture capital company Taiwania Capital. This is the second investment in a Lithuanian company from this USD 200 million fund dedicated to Taiwanese investment in Central and Eastern Europe. Creating AI solutions for radiology “Last year, we received regulatory […]
Deals & Cases / Augustas Klezys, Asta Augutytė-Rapkevičienė, Lina Ragainytė-Mezenė, Ieva Dagytė, Simonas Šlitas, Justina Paškevičienė, Svetlana Rudaja, Goda Drąsutė, Laurynas Kontenis, Goda Jakubauskaitė, Sandra Aleksandravičienė, Andrius Pilitauskas
We advised the French investment company RGREEN INVEST on providing EUR 42 million in funding to the renewable energy company Green Genius. The funds will used to build eight solar projects in Lithuania, with a total capacity of 65.7 MW. Sharing a strong aspiration for sustainability “Faced with the imperative to end European dependence on […]
We advised KGAL Investment Management GmbH & Co. KG (“KGAL”), a leading independent investment and asset manager with an investment volume of €16.5bn, on the leaseback transaction in relation to three new Airbus A220-300 aircraft with Air Baltic Corporation AS, the Latvian national airline and the leading carrier in the Baltic region. The lease agreements […]
We advised AstraZeneca, a global research-based biopharmaceutical company in relation to the company’s participation in a novel public-private partnership to improve lung cancer patient pathway in cooperation and thus contribute jointly to the implementation of the national cancer control plan. New approach National cancer control plan until year 2030 highlights the problem that cancer patients’ […]
